MALE CONTRACEPTIVE
HIV breakthrough: Drug trial shows injection twice a year is 100% effective against infection
The trial tested whether the six-month injection of lenacapavir would provide better protection against HIV infection than two other drugs, both daily pills. All three medications are pre-exposure prophylaxis (or PrEP) drugs.
Drats, there's a rat problem! but hold on to your hats
NYC's rodent infestation prompts unconventional solutions, including a proposed birth control plan using ContraPest. The city's battle against the Malthusian rat population explosion faces scrutiny from animal rights groups and the Chinese zodiac's traits.
UK launches first trial of hormone-free male birth control pill. Details inside
UK trials hormone-free male pill, YCT-529, blocking vitamin A for contraception. Promising, reversible, and side-effect-free; trial ends June 2024.
Weird and wonderful things lost then found inside the human body
The things children are likely to inhale range from the familiar (toys, beads, magnets) to the unexpected (leeches and needles). And inhaled items vary by region. In western countries, it is peanuts that are inhaled the most, with hotdogs causing most deaths.
Long-lasting, reversible contraceptive for men coming soon. ICMR study shows promising results
ICMR has conducted a groundbreaking study on male contraception and found that a non-hormonal injectable contraceptive called RISUG is both safe and effective. The study involved 303 healthy male volunteers and showed that RISUG provides long-lasting sterility while also being reversible. This breakthrough has the potential to transform the field of contraception and give men more control over their reproductive choices.
Health insurance policies beat motor covers in premium
Before the pandemic struck, the share of motor insurance was 37%, as against 27% for health insurance. Motor insurance’s share has dipped to 28% in September, and if premium from personal accident insurance were added to health, its share would be even higher at 41%.
- Go To Page 1
How policy choices can turn India into a hub of global prosperity or of global disorder
If Indians are trained in scientific inquiry, creativity of the technological and aesthetic kinds, and coexistence of diversity, India can become the engine of global peace and prosperity. If, on the other hand, Indians are fed skills, distrust of difference, intolerance of dissent and worship of homogeneity, it would make it a source of global insecurity and disruption.
Mankind Pharma may offer investors a better entry point after its listing
Business: Unlike its peers, Mankind Pharma started in rural India and is now expanding to urban India. The company earns 97% of its revenues from India. It has also been a uniquely successful player in building branded consumer product portfolios. The company is a market leader in multiple categories - male condoms with its brand Manforce, pregnancy detection kits with PregaNews, and emergency contraceptives with its pill Unwanted-72.
Women's health issues need special attentions; Make sure your health insurance cover addresses these
A WHO report indicated that 4.7 million women died from non-communicable diseases in 2012; these deaths were more significant in low-middle-income countries. To add to these was the pandemic-COVID-19, which has added to the woes of women.
Sumeet Vyas gushes about director Sudhir Mishra, says working on his upcoming film ‘Afwaah’ helped him evolve as an actor
'Afwaah' has been described as a quirky thriller with a message.
Rakul Preet Singh’s slice-of-life drama ‘Chhatriwali’ eyes Jan 20 release on ZEE5
The film is produced by Ronnie Screwvala and directed by Tejas Prabha Vijay Deoskar.
Abortion Pill: What is Japan debating?
In such a regressive approach, Japanese women are not allowed to take birthing decisions alone as they will need their partner’s consent to take abortion pill. When women in Japan were anticipating the good news of the approval of the abortion pill to be manufactured by Linepharma International, a British Pharmaceutical Enterprise, they heard something rather regressive.
Family planning vision 2030 to focus on men to check population
Strategies to overcome teenage childbearing, lack of male participation in awareness programmes, migration and lack of access to contraceptives have been identified as priorities in the Centre's family planning vision document 2030 unveiled on Wednesday "Focusing on addressing the teenage childbearing and early/child marriages remain a cause of concern for the country. Married adolescent girls and young women reported high unmet need for contraception," the vision document unveiled in New Delhi by minister of state for health and family welfare Bharati Pravin Pawar said.
TTK Healthcare's 'Love Depot' has Street excited over growth prospects
As per a report published this month by Allied Market Research, a global market research firm, India's sexual wellness market generated $1.15 billion of revenue in 2020 and is expected to reach $2.09 billion in size by 2030, logging a CAGR of 5.8% from 2021 to 2030. Online retail is the major driver of the domestic market where men easily outnumber women as end-users.
India's fertility rate decreases to 2 from 2.2
The National Family Health Survey (NFHS-5) published by the ministry on Friday said the study also showed knowledge of contraceptives was almost universal, with 99% married women and men aware of at least one modern method of contraception, although only 56.4% used them.
Male contraceptive pill found 99% effective in mice
Ever since the female birth control pill was first approved in the 1960s, researchers have been interested in a male equivalent.
Significant progress made in health outcomes: Economic Survey
The survey also credited the increase in institutional deliveries and improvement in maternal health to better infrastructure and improved access to contraceptives.
Covid antiviral drug Molnupiravir has 'major safety concerns', says ICMR
Flagging the various health concerns surrounding the Covid anti-viral drug Molnupiravir, ICMR’s Dr Balram Bhargava said that Merck’s coronavirus pill has not been added to the national treatment protocol due to some ‘major safety concerns.’
Covid-19 drug Molnupiravir flagged for 'major safety concerns'
Molnupiravir has major safety concerns including teratogenicity, mutagenicity, muscle and bone damage.
NFHS finding on fall in fertility rate busts population explosion myth: Population Foundation of India
The National Family Health Survey's (NHFS-5) finding that total fertility rate (TFR) has fallen from 2.2 to 2.0 busts the population explosion myth and shows that India must steer away from coercive measures of population control, the Population Foundation of India said/
Population stabilising; over half of women, kids anaemic, says new health survey
The fifth survey was conducted between 2019 and 2021 in two phases. Arunachal Pradesh, Chandigarh, Chhattisgarh, Haryana, Jharkhand, Madhya Pradesh, National Capital Territory of Delhi, Odisha, Puducherry, Punjab, Rajasthan, Tamil Nadu, Uttar Pradesh and Uttarakhand were surveyed in phase 2. Except for Madhya Pradesh, Rajasthan, Jharkhand and Uttar Pradesh, all states surveyed have achieved the replacement level.
UP population control bill draws ire from Hindu bodies; experts advise caution, more dialogue
Vishwa Hindu Parishad (VHP) international working president Alok Kumar said the proposal to incentivise couples to have just one child will further the demographic imbalance in society. “The government should think again about this because it leads to negative growth in population.”
An unequal music: Only half of women in developing world feel free to make decisions about contraception, says report
From abortion services to virginity tests, women are forced to give up control over their bodies.
New male contraceptive pill is safe, and doesn't affect libido
The contraceptive, called 11-beta-MNTDC, is a modified testosterone.
Revealed: The truth behind the 'emergency contraceptive pill'
Morning-after pills, doctors say, should be used to prevent pregnancy only in the case of an unexpected lapse such as a condom break.
One step closer towards male contraceptive
Researchers led by Gunda I Georg, of the University of Minnesota College of Pharmacy, have taken a promising step towards creating a male contraceptive.
Coming soon: Unisex contraceptive pills
Today, doctors are unable to determine the cause of nearly 80% of all cases of male infertility.
Delhi High Court sets aside cap on condom prices
Delhi High Court today revoked two orders of the pharma pricing authority to cap condom prices, saying these were "illegal and unsustainable".
New research may lead to male contraceptive
The evidence indicates that the protein, ESP1, is stabilising the area where the sperm-egg fusion is occurring.
Load More
